Enlightened Opinion

Partners4Access > Enlightened Opinion

CDF to save NHS £140m over five years

cdf-to-save-nhs-140m-over-five-years

The Cancer Drugs Fund (CDF) is expected to save the U.K. National Health Service (NHS) a minimum of £140 million over the next five years. Medicines that are recommended to the CDF by NICE (National Institute of Health and Care Excellence) have their prices negotiated lower than the manufacturer’s initial listed price. Over 15,000 patients […]

Read More

Webinar 2: What is the optimal US payer program to enable gene therapy patient access?

In the second of three webinars, P4A is focussing on the US environment for gene therapies. Single application cell and gene therapies in the US face health insurance challenges driven by a short-term focus, disconnection between price reporting and outcomes value, and complex distribution models…

Read More

Conferences

In our mission to understand and influence the debate on Orphan Drugs, P4A will be closely following industry and scientific conferences including attending some of them.

All Rights Reserved © Partners 4 Access 2018